<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22792" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hepatitis D</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Masood</surname>
            <given-names>Umair</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>John</surname>
            <given-names>Savio</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Umair Masood declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Savio John declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22792.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hepatitis D virus (HDV) is a unique pathogen that requires the presence of hepatitis B virus (HBV) for its replication and spread. HDV uses the HBV surface antigen as its envelope protein, making it dependent on the coinfection or superinfection with HBV to cause disease. Clinically, HDV infection can lead to more severe liver disease than HBV alone. In acute HBV-HDV coinfection, patients may experience a biphasic course with 2 distinct peaks in serum alanine aminotransferase, reflecting the sequential spread of HBV and HDV. Chronic infection with both viruses can result in faster progression to cirrhosis and liver failure. HDV also has the unique characteristic of suppressing HBV replication, although the mechanism remains unknown. Timely serological testing is crucial for identifying HDV infection in patients with HBV, as this coinfection requires specific management approaches.</p>
        <p>Participants in this course gain a comprehensive understanding of HDV, including its dependence on HBV for transmission, the clinical presentation of coinfection, and the associated complications. They learn how to evaluate patients with suspected HDV by conducting appropriate serological tests and recognize the importance of early diagnosis in improving outcomes. The course emphasizes the role of an interprofessional healthcare team, including hepatologists, infectious disease specialists, and nurses, in providing holistic care. Collaborating with this team enhances patient outcomes by ensuring that the complexities of managing HBV-HDV coinfection are addressed through coordinated efforts, tailored treatment plans, and comprehensive monitoring strategies.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the key clinical features of hepatitis D virus infection in patients with chronic hepatitis B virus.</p></list-item><list-item><p>Screen patients who are positive for hepatitis B-positive for hepatitis D virus coinfection using appropriate serological tests.</p></list-item><list-item><p>Differentiate between acute and chronic&#x000a0;hepatitis B and hepatitis D virus coinfection based on clinical presentation and laboratory findings.</p></list-item><list-item><p>Coordinate care among the interprofessional healthcare team, including hepatologists, infectious disease specialists, and nurses to develop comprehensive treatment plans for patients with hepatitis B and hepatitis D virus coinfection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22792&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22792">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22792.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hepatitis D virus (HDV) was discovered in 1977 in patients with chronic hepatitis B virus (HBV) infection.<xref ref-type="bibr" rid="article-22792.r1">[1]</xref> Originally thought to be an unrecognized HBV antigen, the HDV nuclear antigen was later discovered to be a part of a new pathogen, initially known as the delta agent. HDV is considered a hybrid virus as it uses Hepatitis B surface antigen (HBsAg) as its envelope protein, rendering it able to infect only patients that concomitantly harbor HBV.<xref ref-type="bibr" rid="article-22792.r2">[2]</xref> Due to unknown reasons, HBV replication is suppressed in HDV-infected individuals.<xref ref-type="bibr" rid="article-22792.r3">[3]</xref></p>
      </sec>
      <sec id="article-22792.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>HDV infection is an acute and chronic inflammatory process transmitted parenterally.&#x000a0;HDV replicates independently within hepatocytes but requires HBsAg for propagation. Hepatic cell death occurs due to direct cytotoxic effects of&#x000a0;HDV or a host-mediated immune response.<xref ref-type="bibr" rid="article-22792.r2">[2]</xref>&#x000a0;Risk factors include blood transfusions&#x000a0;and intravenous drug use.<xref ref-type="bibr" rid="article-22792.r4">[4]</xref></p>
      </sec>
      <sec id="article-22792.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Even though HDV is dependent on HBV, its geographical distribution differs from that of HBV, partly due to the differences in mode of transmission. HDV is mainly transmitted via the parenteral route through blood or blood product exposure.&#x000a0;Although sexual transmission is infrequent, vertical transmission is rare.<xref ref-type="bibr" rid="article-22792.r5">[5]</xref><xref ref-type="bibr" rid="article-22792.r6">[6]</xref>&#x000a0;Information on HDV epidemiology has mostly been obtained from HBV carriers who are superinfected with HDV; approximately 5% of the HBV carriers are estimated to also be infected with HDV.<xref ref-type="bibr" rid="article-22792.r7">[7]</xref>&#x000a0;Recently, there has been a significant decline in HDV transmission due to the decrease in the incidence of HBV infection; this is mainly due to improved socioeconomic conditions, increased awareness of infectious disease transmission, and improved&#x000a0;HBV vaccination rates.<xref ref-type="bibr" rid="article-22792.r7">[7]</xref> HDV is most prevalent in the Mediterranean, East Africa, the Amazon basin, the Middle East, Central and Northern Asia, and certain areas of the Pacific.<xref ref-type="bibr" rid="article-22792.r8">[8]</xref> In Western countries, HDV infection is infrequent and occurs only in high-risk populations such as intravenous drug users,&#x000a0;individuals from areas with a high prevalence of HDV, and recipients of multiple transfusions.&#x000a0;</p>
      </sec>
      <sec id="article-22792.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Structurally, HDV comprises a ribonucleic acid (RNA) genome, hepatitis D antigen (HDAg), and a lipoprotein envelope from HBV. The genome only codes for the HDAg. There are&#x000a0;2 types of HDAgs, which are named after their size: long and short. Viral replication occurs in the hepatocytes, and the virus is unique as it uses the host RNA polymerase II to transcribe its messenger RNA.&#x000a0;Although the short HDAg activates viral replication via direct binding to the HDV RNA, the long HDAg directs viral assembly and inhibits viral replication. The virus is completely assembled after incorporating the HBV envelope, after which it is released.<xref ref-type="bibr" rid="article-22792.r2">[2]</xref><xref ref-type="bibr" rid="article-22792.r9">[9]</xref><xref ref-type="bibr" rid="article-22792.r10">[10]</xref></p>
        <p>HDV infection only occurs in the presence of HBV. In individuals susceptible to HBV, coinfection with both viruses results in an acute&#x000a0;HBV and&#x000a0;HBD infection. Clinically, coinfection resembles classic acute HBV, except for a biphasic course of 2 peaks of serum alanine aminotransferase, which may be seen several weeks apart. This is because HBV infection must be established first during the acute coinfection before HDV starts to spread. More severe cases than acute HBV mono-infection may be seen in some cases with an increased risk for liver failure. Most patients recover during the acute coinfection with HBV and HDV, and only about 5% of the patients go on to develop chronic infection (defined as persistence of infection beyond 6 months).<xref ref-type="bibr" rid="article-22792.r5">[5]</xref><xref ref-type="bibr" rid="article-22792.r11">[11]</xref></p>
        <p>In individuals who are chronic carriers of HBsAg, a full-blown superinfection can occur, which may present as severe acute hepatitis or exacerbation of preexisting chronic HBV. In patients with chronic HBV infection, acute HDV infection may be mistaken for&#x000a0;an HBV virus flare. In those with undiagnosed&#x000a0;HBV infection, clinical presentation and initial investigations may be mistaken for acute HBV infection if HDV superinfection is not entertained as a diagnostic possibility. The clinical course during a superinfection is often more severe than HBV/HDV coinfection. As the presence of HBsAg allows for continuous viral replication, 90% of these individuals progress to chronic HDV. Chronic HDV infection causes more severe morbidity and complications (progressive fibrosis, cirrhosis, hepatocellular carcinoma, and hepatic decompensation) than chronic HBV infection.<xref ref-type="bibr" rid="article-22792.r12">[12]</xref>&#x000a0;In cases of triple infection with HBV,&#x000a0; hepatitis C virus (HCV), and HDV, either HDV or HCV will dominate the other viruses depending on the geographic region, host immune factors, activity, and genotype of the HDV involved.&#x000a0;</p>
        <p>Although the mechanism by which HDV induces liver damage is not entirely known, it is thought to be due to the host immune response.<xref ref-type="bibr" rid="article-22792.r13">[13]</xref>&#x000a0;The spectrum of damage can range from no symptoms to fulminant liver failure. HDV superinfection tends to have a more rapid course and increases the risk of hepatocellular carcinoma.<xref ref-type="bibr" rid="article-22792.r14">[14]</xref>&#x000a0;The degree of injury depends on various factors, including HDV genotype, host immune response, and HBV genotype. Classically, there are&#x000a0;3 main HDV genotypes: 1, 2, and 3. Additionally, other genotypes have been identified but are not yet as well characterized. Genotype 1 is the predominant type in Western countries.<xref ref-type="bibr" rid="article-22792.r15">[15]</xref> When associated with acute hepatitis D, it has a fulminant course. Once chronic, it can exacerbate previously existing HBV disease and can rapidly progress toward liver cirrhosis, but it can also have an indolent course. Genotype 2 is most common in the far East countries. Contrary to genotype 1, it is less frequently associated with fulminant liver disease and the progression of chronic liver disease.<xref ref-type="bibr" rid="article-22792.r16">[16]</xref> Genotype 3 is most prevalent in South America and tends to cause severe acute hepatitis, which can progress to liver failure.<xref ref-type="bibr" rid="article-22792.r17">[17]</xref></p>
      </sec>
      <sec id="article-22792.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>HDV&#x000a0;causes the same histological changes in the liver parenchyma as other viral infections and can result in necrosis and inflammation of the hepatic cells. In acute disease, there is intralobular infiltration of inflammatory cells (lymphocytes, macrophages) and cytoplasmic eosinophilia. Chronic hepatitis is characterized by periportal necrosis and is often accompanied by nodular changes.</p>
      </sec>
      <sec id="article-22792.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Hepatitis D is clinically similar to other forms of hepatic viral infections. Most patients&#x000a0;are asymptomatic, but signs and symptoms can include fever, abdominal pain, nausea, vomiting, jaundice, confusion, bruising, or bleeding, depending on the severity of the illness.</p>
      </sec>
      <sec id="article-22792.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>In response to the HDAg, antibodies of the immunoglobulin M (IgM) and immunoglobulin G (IgG class) (anti-HDV) are produced. The&#x000a0;3 infective patterns (acute HDV/HBV coinfection, acute HDV superinfection, and chronic HDV infection) vary concerning appearance and levels of HDV RNA, HDAg, and anti-HDV as well as HBV markers (see <bold>Image.</bold> Hepatitis D&#x000a0;Stages and&#x000a0;Serological&#x000a0;Markers). As HDV depends on HBV, the presence of HBsAg is essential for diagnosis. Additionally, IgM antibody to hepatitis B core antigen (IgM anti-HBc) is necessary to diagnose acute HBV/HDV coinfection.<xref ref-type="bibr" rid="article-22792.r18">[18]</xref></p>
        <p>In acute HDV infection, the appearance of HDAg is early but short-lived and often requires repeat testing for detection. The appearance of anti-HDV is late in acute infection and may be the only way to diagnose acute HDV if other HDV infection markers are absent. The pattern of the IgM class of anti-HDV depends on the course of acute hepatitis D. If HDV infection is self-limited, the appearance of anti-HDV IgM is transient and delayed.<xref ref-type="bibr" rid="article-22792.r18">[18]</xref><xref ref-type="bibr" rid="article-22792.r19">[19]</xref><xref ref-type="bibr" rid="article-22792.r20">[20]</xref> If HDV infection progresses to chronicity, anti-HDV IgM is found in high titers and for a prolonged duration. Anti-HDV IgM is found in acute HDV infection but is not very specific as it is also found in chronic HDV infection.<xref ref-type="bibr" rid="article-22792.r21">[21]</xref><xref ref-type="bibr" rid="article-22792.r22">[22]</xref></p>
        <p>Historically, HDAg detection was considered the gold standard for diagnosis of active HBV infection. As anti-HDV forms immune complexes with HDAg, detecting HDAg by the required immunoblot assay is difficult and time-consuming. Therefore, HDV RNA detection via reverse transcriptase-polymerase chain reaction (RT-PCR) is the most sensitive and practical test for detecting active HDV infection.<xref ref-type="bibr" rid="article-22792.r23">[23]</xref><xref ref-type="bibr" rid="article-22792.r24">[24]</xref></p>
        <p>High-risk individuals (intravenous drug users, individuals from HDV-endemic areas) or those who present with severe course who have acute hepatitis B should be suspected of HDV coinfection. As mentioned, patients with coinfection have high titers of IgM anti-HBc. In these individuals, HDV markers can come before or after HBV markers. Occasionally, patients who present during the second phase of biphasic hepatitis seroconvert to anti-HBs, but they could still test positive for high titer IgM anti-HBc. When the etiology of hepatitis is undetermined in chronic HBV carriers, HDV testing should be performed to rule out an acute HDV superinfection. Distinguishing between HDV superinfection and HBV/HDV coinfection can be difficult when superinfection occurs in unidentified chronic HBV carriers.&#x000a0;</p>
        <p>In individuals with chronic hepatitis B, HDV testing should be considered in high-risk individuals to rule out concurrent chronic HDV infection. This can be obtained by the detection of total anti-HDV antibody followed by confirmatory staining for HDAg in liver tissues and/or measurement of serum HDV RNA. As HBV replication is suppressed in chronic HDV infection, hepatitis B e-antibodies are typically present.</p>
      </sec>
      <sec id="article-22792.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment options for&#x000a0;HDV are limited, and optimal treatment is not known; there are no known treatments for acute HDV. Although not United States Food and Drug Administration-approved for chronic HDV, interferon alpha (IFN alpha) is beneficial in most clinical trials.<xref ref-type="bibr" rid="article-22792.r25">[25]</xref> The pegylated form of IFN alpha is recommended as the preferred agent per expert guidelines. Treatment is administered once weekly for at least&#x000a0;1 year.<xref ref-type="bibr" rid="article-22792.r26">[26]</xref>&#x000a0;The goal of treatment is to suppress HDV replication, which is shown by the inability to detect HDV RNA in serum and HDAg in the liver. Treatment end-points include&#x000a0;normalization of alanine aminotransferase and inflammation on liver biopsy. When the&#x000a0;disease progresses to cirrhosis, liver transplantation is the only viable option.</p>
      </sec>
      <sec id="article-22792.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for HDV&#x000a0;include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alcoholic hepatitis</p>
          </list-item>
          <list-item>
            <p>Autoimmune hepatitis</p>
          </list-item>
          <list-item>
            <p>Budd-Chiari syndrome</p>
          </list-item>
          <list-item>
            <p>Cholangitis</p>
          </list-item>
          <list-item>
            <p>Cholecystitis</p>
          </list-item>
          <list-item>
            <p>HDA</p>
          </list-item>
          <list-item>
            <p>HDB</p>
          </list-item>
          <list-item>
            <p>HDC</p>
          </list-item>
          <list-item>
            <p>Liver abscess</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22792.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>As HDV depends on HBV, prevention can be achieved with&#x000a0;HBV vaccination. If the host is immune to HBV, they are subsequently protected against HDV. Patients at risk of contracting HDV infection should be encouraged to receive the hepatitis B vaccine.</p>
      </sec>
      <sec id="article-22792.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>HDV&#x000a0;only occurs in patients with HBV. Thus, healthcare&#x000a0;professionals should consider serological testing for HDV in patients with HBV. This can be obtained by detecting total anti-HDV antibodies followed by confirmatory staining for HDAg in liver tissues or measuring serum HDV RNA. As HBV replication is suppressed in chronic HDV infection, anti-HBe are typically present. As HDV depends on HBV, prevention can be achieved with&#x000a0;HBV vaccination. If the host is immune to HBV, they are subsequently protected against HDV. Patients who are at risk of contracting HDV infection should be encouraged to receive the&#x000a0;HBV vaccine.&#x000a0;Currently, there is no specific treatment for HDV, but unlike HBV, the former is a benign infection.</p>
      </sec>
      <sec id="article-22792.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22792&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22792">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/hepatitis-d/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22792">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22792/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22792">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22792.s14">
        <fig id="article-22792.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Hepatitis D Stages, Serological Markers, and the Three Infective Patterns. The three infective patterns vary&#x000a0;in appearance and levels of HDV RNA, HDAg, and anti-HDV and&#x000a0;HBV markers. Contributed by U Masood, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Hepatitis__D" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22792.s15">
        <title>References</title>
        <ref id="article-22792.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Canese</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Gerin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Sly</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.</article-title>
            <source>J Infect Dis</source>
            <year>1980</year>
            <month>May</month>
            <volume>141</volume>
            <issue>5</issue>
            <fpage>590</fpage>
            <page-range>590-602</page-range>
            <pub-id pub-id-type="pmid">6989929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polson</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Bass</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase.</article-title>
            <source>Nature</source>
            <year>1996</year>
            <month>Apr</month>
            <day>04</day>
            <volume>380</volume>
            <issue>6573</issue>
            <fpage>454</fpage>
            <page-range>454-6</page-range>
            <pub-id pub-id-type="pmid">8602246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiesslich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Crispim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>Fde L</given-names>
              </name>
              <name>
                <surname>Fraiji</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Komninakis</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.</article-title>
            <source>J Infect Dis</source>
            <year>2009</year>
            <month>Jun</month>
            <day>01</day>
            <volume>199</volume>
            <issue>11</issue>
            <fpage>1608</fpage>
            <page-range>1608-11</page-range>
            <pub-id pub-id-type="pmid">19388852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>EU</given-names>
              </name>
              <name>
                <surname>Thio</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Tobian</surname>
                <given-names>AAR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016.</article-title>
            <source>Clin Infect Dis</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>709</fpage>
            <page-range>709-712</page-range>
            <pub-id pub-id-type="pmid">30605508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liaw</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sheen</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study.</article-title>
            <source>J Infect Dis</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>162</volume>
            <issue>5</issue>
            <fpage>1170</fpage>
            <page-range>1170-2</page-range>
            <pub-id pub-id-type="pmid">2121838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weisfuse</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Hadler</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Alter</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>O'Malley</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Judson</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Ostrow</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>NL</given-names>
              </name>
            </person-group>
            <article-title>Delta hepatitis in homosexual men in the United States.</article-title>
            <source>Hepatology</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>872</fpage>
            <page-range>872-4</page-range>
            <pub-id pub-id-type="pmid">2714738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaeta</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Stroffolini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiaramonte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ascione</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stornaiuolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lobello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagnelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Brunetto</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Chronic hepatitis D: a vanishing Disease? An Italian multicenter study.</article-title>
            <source>Hepatology</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>4 Pt 1</issue>
            <fpage>824</fpage>
            <page-range>824-7</page-range>
            <pub-id pub-id-type="pmid">11003629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wedemeyer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Manns</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead.</article-title>
            <source>Nat Rev Gastroenterol Hepatol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-40</page-range>
            <pub-id pub-id-type="pmid">20051970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Negro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Korba</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Forzani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baroudy</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Gerin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ponzetto</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks.</article-title>
            <source>J Virol</source>
            <year>1989</year>
            <month>Apr</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>1612</fpage>
            <page-range>1612-8</page-range>
            <pub-id pub-id-type="pmid">2926865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ni</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lempp</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Mehrle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nkongolo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>F&#x000e4;lth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stindt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>K&#x000f6;niger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nassal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kubitz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>S&#x000fc;ltmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Urban</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.</article-title>
            <source>Gastroenterology</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>146</volume>
            <issue>4</issue>
            <fpage>1070</fpage>
            <page-range>1070-83</page-range>
            <pub-id pub-id-type="pmid">24361467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smedile</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Verme</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caredda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cargnel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caporaso</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dentico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trepo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Opolon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gimson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vergani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Influence of delta infection on severity of hepatitis B.</article-title>
            <source>Lancet</source>
            <year>1982</year>
            <month>Oct</month>
            <day>30</day>
            <volume>2</volume>
            <issue>8305</issue>
            <fpage>945</fpage>
            <page-range>945-7</page-range>
            <pub-id pub-id-type="pmid">6127458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smedile</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dentico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zanetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sagnelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nordenfelt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Actis</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Infection with the delta agent in chronic HBsAg carriers.</article-title>
            <source>Gastroenterology</source>
            <year>1981</year>
            <month>Dec</month>
            <volume>81</volume>
            <issue>6</issue>
            <fpage>992</fpage>
            <page-range>992-7</page-range>
            <pub-id pub-id-type="pmid">7286594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bichko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Netter</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis associated with replication of hepatitis delta virus.</article-title>
            <source>Infect Agents Dis</source>
            <year>1994</year>
            <season>Apr-Jun</season>
            <volume>3</volume>
            <issue>2-3</issue>
            <fpage>94</fpage>
            <page-range>94-7</page-range>
            <pub-id pub-id-type="pmid">7812659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romeo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Del Ninno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sangiovanni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Franchis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ronchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.</article-title>
            <source>Gastroenterology</source>
            <year>2009</year>
            <month>May</month>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>1629</fpage>
            <page-range>1629-38</page-range>
            <pub-id pub-id-type="pmid">19208358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niro</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Smedile</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andriulli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The predominance of hepatitis delta virus genotype I among chronically infected Italian patients.</article-title>
            <source>Hepatology</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>728</fpage>
            <page-range>728-34</page-range>
            <pub-id pub-id-type="pmid">9049226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Choo</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Huo</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.</article-title>
            <source>Lancet</source>
            <year>1995</year>
            <month>Oct</month>
            <day>07</day>
            <volume>346</volume>
            <issue>8980</issue>
            <fpage>939</fpage>
            <page-range>939-41</page-range>
            <pub-id pub-id-type="pmid">7564729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casey</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wignall</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Gerin</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A genotype of hepatitis D virus that occurs in northern South America.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1993</year>
            <month>Oct</month>
            <day>01</day>
            <volume>90</volume>
            <issue>19</issue>
            <fpage>9016</fpage>
            <page-range>9016-20</page-range>
            <pub-id pub-id-type="pmid">8415646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aragona</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macagno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caredda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Crivelli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lavarini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maran</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Farci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serological response to the hepatitis delta virus in hepatitis D.</article-title>
            <source>Lancet</source>
            <year>1987</year>
            <month>Feb</month>
            <day>28</day>
            <volume>1</volume>
            <issue>8531</issue>
            <fpage>478</fpage>
            <page-range>478-80</page-range>
            <pub-id pub-id-type="pmid">2881041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shattock</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source.</article-title>
            <source>J Med Virol</source>
            <year>1984</year>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-82</page-range>
            <pub-id pub-id-type="pmid">6363622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jard&#x000ed;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Guardia</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Serological diagnosis of acute delta hepatitis.</article-title>
            <source>J Med Virol</source>
            <year>1986</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-5</page-range>
            <pub-id pub-id-type="pmid">3944592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heermann</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerlich</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope.</article-title>
            <source>J Virol</source>
            <year>1986</year>
            <month>Jun</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>945</fpage>
            <page-range>945-50</page-range>
            <pub-id pub-id-type="pmid">3701932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jardi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodriguez-Frias</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Casacuberta</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Allende</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guardia</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication.</article-title>
            <source>Hepatology</source>
            <year>1989</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>907</fpage>
            <page-range>907-10</page-range>
            <pub-id pub-id-type="pmid">2583685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinolfo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Abate</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bertolo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bosio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rosina</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cavicchini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rizzetto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Negro</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay.</article-title>
            <source>Int J Clin Lab Res</source>
            <year>1995</year>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">7787208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mederacke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bremer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heidrich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kirschner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deterding</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bock</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wursthorn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Manns</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Wedemeyer</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.</article-title>
            <source>J Clin Microbiol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>6</issue>
            <fpage>2022</fpage>
            <page-range>2022-9</page-range>
            <pub-id pub-id-type="pmid">20351206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbas</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Salih</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jafri</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Interferon alpha for chronic hepatitis D.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2011</year>
            <month>Dec</month>
            <day>07</day>
            <volume>2011</volume>
            <issue>12</issue>
            <fpage>CD006002</fpage>
            <pub-id pub-id-type="pmid">22161394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22792.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrault</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lok</surname>
                <given-names>ASF</given-names>
              </name>
              <name>
                <surname>McMahon</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bzowej</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.</article-title>
            <source>Hepatology</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>1560</fpage>
            <page-range>1560-1599</page-range>
            <pub-id pub-id-type="pmid">29405329</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
